MIR-301b-3p Promotes Lung Adenocarcinoma Cell Proliferation, Migration and Invasion by Targeting DLC1

Overview

Journal Technol Cancer Res Treat

Specialties Biomedical Engineering
Oncology
Pharmacology

Date 2021 Mar 23

PMID 33754907

Citations 11

Authors

Haitao Liu

Xingjie Ma

Niu Niu

Junjie Zhao

Chao Lu

Fan Yang

Weibo Qi

Affiliations

Soon will be listed here.

Abstract

Background: miR-301b-3p is reported in various human cancers for its abnormal expression, while the role and molecular mechanisms in lung adenocarcinoma (LUAD) remain unclear, and this is the focus of the present study.

Materials And Methods: TCGA database was consulted to know gene expression in LUAD tissue. CCK-8, colony formation assay and Transwell assay were applied to identify the role of target genes in regulating LUAD cell biological properties. Bioinformatics analysis plus dual-luciferase assay were performed to validate the potential connection between genes.

Results: miR-301b-3p and DLC1 were the target genes of this study and respectively differentially up-regulated and down-regulated in LUAD. Functional experiments indicated that miR-301b-3p contributed to cancer cell proliferation, migration and invasion, while this effect was reversed with overexpressed DLC1 which was identified as a direct target of and regulated by miR-301b-3p.

Conclusions: Collectively, miR-301b-3p was identified to actively function on LUAD malignant progression by suppressing DLC1 expression. This discovery provides a novel therapeutic strategy for LUAD patients, which helps improve the survival of patients.

Citing Articles

MiR-301b-3p targets and regulates EBF3 to impact the stem-like phenotype of breast cancer cells through glycolysis.

Huang J, Zhen W, Ma X, Ge S, Ma L J Clin Biochem Nutr. 2025; 76(1):25-34.

PMID: 39896160 PMC: 11782780. DOI: 10.3164/jcbn.23-131.

MiR-301b-3p promotes breast cancer development through inhibiting the expression of transforming growth factor-beta receptor 2.

Lou J, Liu X, Xie Y, Wu M, Mao W, Ying X PeerJ. 2024; 12:e18324.

PMID: 39525474 PMC: 11546148. DOI: 10.7717/peerj.18324.

MicroRNAs: circulating biomarkers for the early detection of imperceptible cancers via biosensor and machine-learning advances.

Metcalf G Oncogene. 2024; 43(28):2135-2142.

PMID: 38839942 PMC: 11226400. DOI: 10.1038/s41388-024-03076-3.

MicroRNA 211-5p inhibits cancer cell proliferation and migration in pancreatic cancer by targeting BMP2.

Li D, Luo C, Deng J, Xu Y, Fu S, Liu K Aging (Albany NY). 2023; 15(23):14411-14421.

PMID: 38059889 PMC: 10756115. DOI: 10.18632/aging.205320.

The oncogenic miR-429 promotes triple-negative breast cancer progression by degrading DLC1.

Li Y, Meng X, Luo Y, Luo S, Li J, Zeng J Aging (Albany NY). 2023; 15(18):9809-9821.

PMID: 37737712 PMC: 10564445. DOI: 10.18632/aging.205051.

References

Zhou S, Yin D, Hu Z, Luo C, Zhou Z, Xin H . A Positive Feedback Loop Between Cancer Stem-Like Cells and Tumor-Associated Neutrophils Controls Hepatocellular Carcinoma Progression. Hepatology. 2019; 70(4):1214-1230. DOI: 10.1002/hep.30630. View

Li P, Xing W, Xu J, Yuan D, Liang G, Liu B . microRNA-301b-3p downregulation underlies a novel inhibitory role of long non-coding RNA MBNL1-AS1 in non-small cell lung cancer. Stem Cell Res Ther. 2019; 10(1):144. PMC: 6528355. DOI: 10.1186/s13287-019-1235-8. View

Tan W, Jain A, Takano A, Newell E, Iyer N, Lim W . Novel therapeutic targets on the horizon for lung cancer. Lancet Oncol. 2016; 17(8):e347-e362. DOI: 10.1016/S1470-2045(16)30123-1. View

Zhang T, Zheng J, Liu C, Lu Y . Expression of DLC-1 in clear cell renal cell carcinoma: prognostic significance for progression and metastasis. Urol Int. 2009; 82(4):380-7. DOI: 10.1159/000218524. View

Zheng H, Bai L . Hypoxia induced microRNA-301b-3p overexpression promotes proliferation, migration and invasion of prostate cancer cells by targeting LRP1B. Exp Mol Pathol. 2019; 111:104301. DOI: 10.1016/j.yexmp.2019.104301. View

Herbst R, Morgensztern D, Boshoff C . The biology and management of non-small cell lung cancer. Nature. 2018; 553(7689):446-454. DOI: 10.1038/nature25183. View

Torre L, Siegel R, Jemal A . Lung Cancer Statistics. Adv Exp Med Biol. 2015; 893:1-19. DOI: 10.1007/978-3-319-24223-1_1. View

Gokmen-Polar Y, True J, Vieth E, Gu Y, Gu X, Qi G . Quantitative phosphoproteomic analysis identifies novel functional pathways of tumor suppressor DLC1 in estrogen receptor positive breast cancer. PLoS One. 2018; 13(10):e0204658. PMC: 6168143. DOI: 10.1371/journal.pone.0204658. View

Man X, Piao C, Lin X, Kong C, Cui X, Jiang Y . USP13 functions as a tumor suppressor by blocking the NF-kB-mediated PTEN downregulation in human bladder cancer. J Exp Clin Cancer Res. 2019; 38(1):259. PMC: 6570860. DOI: 10.1186/s13046-019-1262-4. View

10.

Yang X, Popescu N, Zimonjic D . DLC1 interaction with S100A10 mediates inhibition of in vitro cell invasion and tumorigenicity of lung cancer cells through a RhoGAP-independent mechanism. Cancer Res. 2011; 71(8):2916-25. PMC: 3078213. DOI: 10.1158/0008-5472.CAN-10-2158. View

11.

Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6):394-424. DOI: 10.3322/caac.21492. View

12.

Zappa C, Mousa S . Non-small cell lung cancer: current treatment and future advances. Transl Lung Cancer Res. 2016; 5(3):288-300. PMC: 4931124. DOI: 10.21037/tlcr.2016.06.07. View

13.

Sun C, Zhang L, Li G, Li S, Chen Z, Fu Y . The lncRNA PDIA3P Interacts with miR-185-5p to Modulate Oral Squamous Cell Carcinoma Progression by Targeting Cyclin D2. Mol Ther Nucleic Acids. 2017; 9:100-110. PMC: 5626923. DOI: 10.1016/j.omtn.2017.08.015. View

14.

Li B, Meng Y, Li Z, Yin C, Lin J, Zhu D . MiR-629-3p-induced downregulation of SFTPC promotes cell proliferation and predicts poor survival in lung adenocarcinoma. Artif Cells Nanomed Biotechnol. 2019; 47(1):3286-3296. DOI: 10.1080/21691401.2019.1648283. View

15.

Zhang Z, Chen J, Xia S, Zhao H, Yang J, Zhang H . Long intergenic non-protein coding RNA 319 aggravates lung adenocarcinoma carcinogenesis by modulating miR-450b-5p/EZH2. Gene. 2018; 650:60-67. DOI: 10.1016/j.gene.2018.01.096. View

16.

Torre L, Siegel R, Ward E, Jemal A . Global Cancer Incidence and Mortality Rates and Trends--An Update. Cancer Epidemiol Biomarkers Prev. 2015; 25(1):16-27. DOI: 10.1158/1055-9965.EPI-15-0578. View

17.

Joshi R, Qin L, Cao X, Zhong S, Voss C, Min W . DLC1 SAM domain-binding peptides inhibit cancer cell growth and migration by inactivating RhoA. J Biol Chem. 2019; 295(2):645-656. PMC: 6956525. DOI: 10.1074/jbc.RA119.011929. View

18.

Fan H, Jin X, Liao C, Qiao L, Zhao W . MicroRNA-301b-3p accelerates the growth of gastric cancer cells by targeting zinc finger and BTB domain containing 4. Pathol Res Pract. 2019; 215(11):152667. DOI: 10.1016/j.prp.2019.152667. View

19.

Akagi I, Okayama H, Schetter A, Robles A, Kohno T, Bowman E . Combination of protein coding and noncoding gene expression as a robust prognostic classifier in stage I lung adenocarcinoma. Cancer Res. 2013; 73(13):3821-32. PMC: 6503978. DOI: 10.1158/0008-5472.CAN-13-0031. View

20.

Guo Y, Yao B, Zhu Q, Xiao Z, Hu L, Liu X . MicroRNA-301b-3p contributes to tumour growth of human hepatocellular carcinoma by repressing vestigial like family member 4. J Cell Mol Med. 2019; 23(8):5037-5047. PMC: 6653225. DOI: 10.1111/jcmm.14361. View